IP Library Granted Patent US 9,550,987
Granted Patent B2
US 9,550,987 · App. 14/440,917 · Granted Jan 24, 2017

Riboregulator compositions and methods of use

Inventors: Alexander A. Green (Scottsdale, AZ); Peng Yin (Brookline, MA); James J. Collins (Boston, MA)
Assignees: President and Fellows of Harvard College; Trustees of Boston University
C12N15/11C12N15/113C12N15/115C12N15/67C12Q1/6897C12N2310/17C12Q1/6816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,550,987
App. No.
14/440,917
Granted
Jan 24, 2017
Kind
B2
Abstract

The invention provides novel and versatile classes of riboregulators, including inter alia activating and repressing riboregulators, switches, and trigger and sink RNA, and methods of their use for detecting RNAs in a sample such as a well and in modulating protein synthesis and expression.

Claims (52)

1. A toehold riboregulator comprising

an RNA comprising in a 5′ to 3′ order

(1) a single-stranded toehold domain,

(2) a fully or partially double-stranded stem domain comprising

(i) an initiation codon, and

(ii) a loop domain comprising a ribosome binding site, and

(3) a coding domain.

2. The riboregulator of claim 1 , further comprising a spacer domain.

3. The riboregulator of claim 2 , wherein the spacer domain encodes low molecular weight amino acids.

4. The riboregulator of claim 2 , wherein the spacer is about 9-33 nucleotides in length.

5. The riboregulator of claim 2 , wherein the spacer is about 21 nucleotides in length.

6. The riboregulator of claim 2 , wherein the spacer domain is situated between the stem domain and the coding domain.

7. The riboregulator of claim 1 , wherein the stem domain comprises sequence upstream (5′) and/or downstream (3′) of the initiation codon.

8. The riboregulator of claim 7 , wherein the sequence upstream of the initiation codon is about 6 nucleotides.

9. The riboregulator of claim 7 , wherein the sequence downstream of the initiation codon is about 9 nucleotides.

10. The riboregulator of claim 7 , wherein the sequence downstream of the initiation codon does not encode a stop codon.

11. The riboregulator of claim 1 , wherein the coding domain encodes a reporter protein.

12. The riboregulator of claim 11 , wherein the reporter protein is green fluorescent protein (GFP).

13. The riboregulator of claim 1 , wherein the coding domain encodes a non-reporter protein.

14. The riboregulator of claim 1 , wherein the toehold domain is complementary in sequence to a naturally occurring RNA.

15. The riboregulator of claim 1 , wherein the toehold domain is complementary in sequence to a non-naturally occurring RNA.

16. A trans-activating RNA (taRNA) comprising

a first domain that hybridizes to a toehold domain of a riboregulator of claim 1 and that comprises no or minimal secondary structure, and

a second domain that hybridizes to a sequence in the stem domain of the riboregulator of claim 1 .

17. The trans-activating RNA of claim 16 , wherein the first domain is 100% complementary to the toehold domain.

18. A system comprising

the riboregulator of claim 1 , and

the trans-activating RNA (taRNA) of claim 16 .

19. The system of claim 18 , wherein the system is a cell.

20. The system of claim 19 , wherein the cell is a prokaryotic cell.

21. The system of claim 18 , wherein the system is a cell-free in vitro system.

22. The system of claim 18 , wherein the riboregulator and the taRNA are hybridized to each other.

23. The system of claim 18 , wherein the ratio of riboregulator to taRNA is less than 1, less than 0.5, or less than 0.1.

24. The system of claim 18 , wherein the riboregulator is comprised in a first nucleic acid and the taRNA is comprised in a second nucleic acid.

25. The system of claim 24 , wherein the first nucleic acid is a first plasmid and the second nucleic acid is a second plasmid.

26. The system of claim 24 , wherein the first plasmid comprises a medium copy origin of replication and the second plasmid comprises a high copy origin of replication.

27. A nucleic acid comprising

the riboregulator of claim 1 .

28. A host cell comprising the nucleic acid of claim 27 .

29. A nucleic acid comprising

the trans-activating RNA (taRNA) of claim 16 .

30. A host cell comprising the nucleic acid of claim 29 .

31. A method of detecting presence of an RNA in a sample, comprising

combining a riboregulator of claim 1 with a sample, wherein the riboregulator comprises a toehold domain that is complementary to an endogenous RNA, and wherein the riboregulator comprises a coding domain that encodes a reporter protein, under conditions that allow translation of the coding domain in the presence of the endogenous RNA but not in the absence of the endogenous RNA, and

detecting the reporter protein as an indicator of the endogenous RNA.

32. A method of detecting presence of an RNA in a cell, comprising

introducing into the cell a riboregulator of claim 1 , wherein the riboregulator comprises a toehold domain that is complementary to an endogenous RNA in the cell, and wherein the riboregulator comprises a coding domain that encodes a reporter protein, and

detecting the reporter protein as an indicator of the endogenous RNA.

33. The method of claim 31 , wherein the reporter protein is green fluorescent protein (GFP).

34. The method of claim 31 , wherein amount of reporter protein is an indicator of amount of endogenous RNA.

35. A method of controlling protein translation, comprising

combining a riboregulator of claim 1 with a taRNA of claim 16 , wherein the riboregulator comprises a toehold domain that is complementary to the taRNA, and wherein the riboregulator comprises a coding domain that encodes a non-reporter protein, under conditions that allow translation of the coding domain in the presence of the taRNA but not in the absence of the taRNA.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2015
From: GREEN, ALEXANDER ARTHUR; YIN, PENG
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 036420/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2015
From: COLLINS, JAMES J.; HOWARD HUGHES MEDICAL INSTITUTE
To: TRUSTEES OF BOSTON UNIVERSITY
Reel/Frame 036420/0334 →
APPOINTMENT OF INVESTIGATOR AS AGENT Recorded Aug 26, 2015
From: HOWARD HUGHES MEDICAL INSTITUTE
To: COLLINS, JAMES J.
Reel/Frame 036463/0930 →
CONFIRMATION OF ASSIGNMENT Recorded Aug 26, 2015
From: COLLINS, JAMES J.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 036463/0978 →
CONFIRMATORY LICENSE Recorded May 28, 2015
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035771/0450 →
Continuity (3)
Provisional Application 61722825 · Nov 6, 2012
Provisional Application 61843934 · Jul 9, 2013
Related Publication 20150275203A1 · Oct 1, 2015